Variables and Strategies in Development of Therapeutic Post-Transcriptional Gene Silencing Agents

Post-transcriptional gene silencing (PTGS) agents such as ribozymes, RNAi and antisense have substantial potential for gene therapy of human retinal degenerations. These technologies are used to knockdown a specific target RNA and its cognate protein. The disease target mRNA may be a mutant mRNA cau...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Jack M., Yau, Edwin H., Kolniak, Tiffany A., Sheflin, Lowell G., Taggart, R. Thomas, Abdelmaksoud, Heba E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138052/
https://www.ncbi.nlm.nih.gov/pubmed/21785698
http://dx.doi.org/10.1155/2011/531380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138052/
https://www.ncbi.nlm.nih.gov/pubmed/21785698
http://dx.doi.org/10.1155/2011/531380

Ejemplares similares